The Council for International Organizations of Medical Sciences (CIOMS) is an international, non-governmental, non-profit organization established jointly by WHO and UNESCO in 1949. In 2009 CIOMS celebrated the 60th anniversary of its creation.
Through its membership, CIOMS is representative of a substantial proportion of the biomedical scientific community. In 2013, the membership of CIOMS included 49 international, national and associate member organizations, representing many of the biomedical disciplines, national academies of sciences and medical research councils. The main objectives of CIOMS are:
Read more: About Us
In September 2012 the Working Group on the Revision of the 2002 CIOMS International Ethical Guidelines for Biomedical Research Involving Human Subjects held its first meeting in Geneva. Since then continuous work, including six face-to-face meetings and repeated interaction in between, has resulted in good progress and has kept pace with recent developments in the field of biomedical research and a revised Declaration of Helsinki.
Read more: CIOMS Symposium at the 12th World Congress of the International Association of Bioethics, Mexico...
The April 2014 Newsletter presents reports from the Working Groups on Vaccine Safety, MedDRA, and WHO's MIM, and also introduces the Acting Secretary-General.
click here to read the Newsletter...
Elections were held at the CIOMS 80th Executive Committee Meeting and XXIst General Assembly on 20 November 2013, and we are pleased to announce the following new officers and members:
Read more: General Assembly of CIOMS in Geneva
A CIOMS INTERNATIONAL WORKSHOP on “Considerations on benefit sharing” was held in conjunction with the General Assembly at WHO Headquarters on the same day between 08:45 to 11:45 on Wednesday, 20 November 2013.
Speakers were: Dr Stefano Semplici, Chair, International Bioethics Committee, University of Rome Tor Vergata, Italy; Dr Alex John London, Carnegie Mellon University, Pittsburgh, PA, USA; Dr Ruth Macklin, Albert Einstein College of Medicine, New York, USA; and Dr Dirceu Greco, Federal University of Minas Gerais, Belo Horizonte, Brazil. Dr Rodolfo Saracci chaired the meeting.
CIOMS is very grateful for the contribution from all to a very successful meeting!
In 2010 the Executive Committee of CIOMS decided to revise the CIOMS Ethical Guidelines for Biomedical Research. The document was last revised in 2002 and since then, several developments have taken place, both in the field of biomedical research itself and in the field of research ethics. Among the latter developments is the recent revision of the Declaration of Helsinki in 2013.
Read more: CIOMS Working Group on the Revision of the 2002 CIOMS Ethical Guidelines for Biomedical Research
The CIOMS V Working Group (WG) met in a series of 8 formal meetings during the years 1997 to 2000. The printed version of their report ”Current Challenges in Pharmacovigilance: Pragmatic Approaches” was published in 2001. The CIOMS WG V, through its report, advocated acceptance for a wide range of proposals concerning issues covering terminology and definitions, common every day practices such as follow-up of individual adverse events, the rational scheduling and content of periodic safety update reports (PSURs), the role of internet and quantification of population drug use. The completed report, intended as a handbook for pharmacovigilance departments and still offering many pragmatic solutions to a number of issues, has been in great demand. CIOMS has now decided to make the publication available free of charge to download on its website.
Click here to access the download page
A new CIOMS Working Group (WG) has been established to address issues related to the information exchange between stakeholders on vaccine safety. The formation of the new WG is linked to the activities of the Global Vaccine Safety Blueprint of WHO and its implementation plan, the Global Vaccine Safety Initiative (GVSI). It is a global strategic plan that aims at assisting low- and middle-income countries (LMIC) in their work with vaccine safety surveillance.
The importance of close collaboration between stakeholders is well recognized in vaccine pharmacovigilance activities, and guidance has been developed, in industrialized countries, for jointly planning these activities.
Read more: NEW! CIOMS Working Group on Vaccine Safety
The 1985 International Guiding Principles for Biomedical Research Involving Animals have been revised by an ad hoc committee appointed by the Council for International Organizations of Medical Sciences (CIOMS) and the International Council for Laboratory Animal Science (ICLAS).
The revised International Guiding Principles for Biomedical Research Involving Animals reflect current best practices and standards of care in laboratory animal medicine and science and provide a touchstone or framework of responsibility and oversight to ensure the appropriate use of animals. They also may serve as a benchmark for advancing international collaboration in biomedical sciences.
It is hoped that international organizations and governmental agencies will adopt these revised International Guiding Principles for Biomedical Research Involving Animals and that they will encourage use by the scientific community worldwide.
click here to download document
The Council for International Organizations of Medical Sciences (CIOMS) is happy to announce the above joint publication between the World Health Organization (WHO), CIOMS and one of its new members, the International Union of Basic and Clinical Pharmacology (IUPHAR).
This report is an updated and extended version of a recent publication in Basic and Clinical Pharmacology and Toxicology (BCPT) and includes new chapters of special relevance to global health. CIOMS welcomes IUPHAR as a member.
Read more: New publication: The Role of Clinical Pharmacology in Health Care, Teaching and Research
Page 1 of 2
This report is an updated and extended version of a recent publication in Basic and Clinical P...
5th Vaccine Safety Working Group, Rabat, Morocco, 24-25 September 20148th Working Group X on Meta-analysis, Basel, Switzerland, 30 September – 1 October 2014
MedDRA 6th IWG Meeting, ICH, Geneva, Switzerland, 14-16 October 20147th Working Group on Revision of CIOMS International Ethical Guidelines, Geneva, Switzerland, 12-14 November 201481st CIOMS Executive Committee Meeting, Geneva, Switzerland, 18 November 2014
6th Working Group on Revision of CIOMS International Ethical Guidelines, Geneva, Switzerland, 21-23 May 2014
4th Vaccine Safety Working Group, UMC, Uppsala, Sweden, 20-21 May 2014
5th Working Group on MedDRA, ICH, Geneva, Switzerland, 9-10 April 2014
5th Working Group on Revision of CIOMS International Ethical Guidelines, Utrecht, Netherlands, 26-28 February 2014
7th Working Group X on Meta-analysis, Durham, North Carolina, USA, 25-26 February 2014
3rd Vaccine Safety Working Group, CDC, Atlanta, GA, USA, 5-6 February 2014
CIOMS 80th Executive Committee Meeting, XXI General Assembly & Workshop, 20 November 2013, WHO Headquarters, Geneva, Switzerland
CIOMS 4th Working Group on Revision of CIOMS International Ethical Guidelines, 17-19 November 2013, WHO Headquarters, Geneva, SwitzerlandCIOMS Working Group on Vaccine Safety, 17-18 September 2013, WHO Headquarters, Geneva, Switzerland
CIOMS WG X on Considerations for applying good meta-analysis practices to clinical safety data within the biopharmaceutical regulatory process, 12-13 September 2013, Singapore
CIOMS Working Group on the Review of 2002 International Ethical Guidelines, 26-28 June 2013, UMC, Utrecht, The Netherlands
CIOMS WG on Vaccine Safety, 29-30 May 2013 , EMA, London, UK
CIOMS Working Group on the Review of 2002 International Ethical Guidelines, 11-12 February 2013, Geneva, Switzerland
CIOMS Working Group X, 14-15 March 2013, MEB, Utrecht, The Netherlands
CIOMS Working Group IX, 18-19 March 2013, NDA, Stockholm, Sweden
MedDRA 3rd IWG Meeting, 9-10 April 2013, IFPMA/CIOMS, Geneva, Switzerland
© 2013 CIOMS - All rights reserved